OrthoSera (Group)

Founded in 2012 and located in Krems an der Donau/Austria Lacerta Technologies GmbH is a clinicalstage regenerative medicine company aiming to translate research results into products for routin clinical use. We put special emphasis on designing simple and affordable protocols allowing a wider patient population to benefit from cell therapy. Our current development projects include an innovative albumin-coated bone allograft and a point-ofcare device for the personalised production of autologous serum products. *

	Start	2015-11-26 renamed
	Predecessor	Lacerta Technologies GmbH
	Industry	medical device
	Industry 2	tissue engineering / regenerative medicine
	Person	Lacza, Zsombor (Lacerta Technologies GmbH 201404 CEO + Founder)
	Person 2	Ehring, Björn (Lacerta Technologies GmbH 201404 CFO + Business Angel Investor)

	Region	Krems a. d. Donau
	Country	Austria
	City	n. a.
		Address record changed: 2017-03-03

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2023-06-26

Picture Berlin Partner Top News New Ariceum Radiopharma Lab 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)